Mark Kindy to Amyloidosis
This is a "connection" page, showing publications Mark Kindy has written about Amyloidosis.
Connection Strength
1.060
-
Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci. 2002 Jul 15; 22(14):5900-9.
Score: 0.191
-
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med. 2000 Jun; 6(6):643-51.
Score: 0.165
-
Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins. Amyloid. 2000 Mar; 7(1):32-40.
Score: 0.162
-
A mouse model for serum amyloid A amyloidosis. Methods Enzymol. 1999; 309:701-16.
Score: 0.149
-
Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice. Am J Pathol. 1998 May; 152(5):1387-95.
Score: 0.142
-
Association of apolipoprotein E with murine amyloid A protein amyloid. Lab Invest. 1995 Oct; 73(4):469-75.
Score: 0.119
-
Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci. 2003 Mar 15; 23(6):1992-6.
Score: 0.050
-
Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine. 2000 Sep; 12(9):1337-47.
Score: 0.042
-
Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun. 1996 Sep 24; 226(3):672-80.
Score: 0.032
-
In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice. J Struct Biol. 1998 Dec 01; 124(1):88-98.
Score: 0.009